This federal contract award, valued at $30,158.73, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the delivery of Lamictal XR 200 mg tablets, a medication used in the treatment of mental health conditions. The contract has a firm fixed-price pricing type and an ultimate completion date of October 28, 2024.
Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant presence as a vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems. The company holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Amerisourcebergen maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
This contract award does not have a set-aside designation, indicating open competition. The contract is a delivery order, which allows for the efficient procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 1/24/25, 9:26 AM